While the American Cancer Society does not recommend “routine” prostate-specific antigen screening for men, there's a lot to ...

Former President Biden’s prostate cancer diagnosis is highlighting the importance of screening for one of the most common types of cancer in older men. Biden’s aggressive cancer diagnosis ...

Former President Biden’s prostate cancer diagnosis is highlighting the importance of screening for one of the most common types of cancer in older men. Biden’s aggressive cancer diagnosis ...

When former President Joe Biden announced his diagnosis of prostate cancer on May 19, everything changed for people like ...

Improvements in prostate cancer screening and treatment. Historically, an elevated PSA test led directly to a prostate biopsy, potentially causing unnecessary anxiety and sometimes overtreatment.

Improvements in prostate cancer screening and treatment. Historically, an elevated PSA test led directly to a prostate biopsy, potentially causing unnecessary anxiety and sometimes overtreatment.

Improvements in prostate cancer screening and treatment. Historically, an elevated PSA test led directly to a prostate biopsy, potentially causing unnecessary anxiety and sometimes overtreatment.

Former President Biden’s last known prostate cancer screening was in 2014, a spokesperson for the former president said Tuesday. The acknowledgement that Biden hasn’t been screened in 10 years ...

Biden’s cancer renews debate about prostate screenings for older men. It is not unusual for a man of Biden’s age to skip prostate cancer screening, for a variety of reasons.

Improvements in prostate cancer screening and treatment. Historically, an elevated PSA test led directly to a prostate biopsy, potentially causing unnecessary anxiety and sometimes overtreatment.

Former president Joe Biden’s last known screening for prostate cancer was in 2014, when he was 71 years old and serving as vice president, a spokesperson for Biden’s office said on Tuesday.

Concerns regarding overtreatment led the U.S. Preventive Services Task Force (USPSTF) in 2012 to recommend against routine PSA screening for prostate cancer, researchers noted.